Resting-state functional MRI (fMRI) studies have provided much evidence for abnormal intrinsic brain activity in schizophrenia, but results have been inconsistent. Methods: We conducted a meta-analysis of whole-brain, resting-state fMRI studies that explored differences in amplitude of low-frequency fluctuation (ALFF) between people with schizophrenia (including first episode and chronic) and healthy controls. Results: A systematic literature search identified 24 studies comparing a total of 1249 people with schizophrenia and 1179 healthy controls. Overall, patients with schizophrenia displayed decreased ALFF in the bilateral postcentral gyrus, bilateral precuneus, left inferior parietal gyri and right occipital lobe, and increased ALFF in the right putamen, right inferior frontal gyrus, left inferior temporal gyrus and right anterior cingulate cortex. In the subgroup analysis, patients with first-episode schizophrenia demonstrated decreased ALFF in the bilateral inferior parietal gyri, right precuneus and left medial prefrontal cortex, and increased ALFF in the bilateral putamen and bilateral occipital gyrus. Patients with chronic schizophrenia showed decreased ALFF in the bilateral postcentral gyrus, left precuneus and right occipital gyrus, and increased ALFF in the bilateral inferior frontal gyri, bilateral superior frontal gyrus, left amygdala, left inferior temporal gyrus, right anterior cingulate cortex and left insula. Limitations: The small sample size of our subgroup analysis, predominantly Asian samples, processing steps and publication bias could have limited the accuracy of the results. Conclusion: Our comprehensive meta-analysis suggests that findings of aberrant regional intrinsic brain activity during the initial stages of schizophrenia, and much more widespread damage with the progression of disease, may contribute to our understanding of the progressive pathophysiology of schizophrenia.
Introduction
Schizophrenia is one of the most severe psychiatric illnesses, typically associated with complex and diverse impairments in cognitive and affective behaviour and perceptual levels of processing, with a lifetime prevalence of 0.30% to 0.66% in the general population. 1 Schizophrenia places a huge burden on patients, families and society, and continues to be a debilitatingly progressive and incurable condition. Schizophrenia is a prototypical disorder of brain connectivity that results in a classic collection of signs and symptoms, primarily starting with paranoid delusions and auditory hallucinations in adolescence or early adulthood. [2] [3] [4] Although many studies of schizophrenia have been conducted over the last century, the pathophysiology of schizophrenia is yet to be fully illuminated.
Over the past decade, resting-state functional MRI (fMRI) has become a promising tool for the in vivo exploration of brain activity and connectivity, greatly enhancing our under standing of the pathophysiology of schizophrenia. [5] [6] [7] [8] [9] [10] [11] [12] [13] In recent years, amplitude of low-frequency fluctuation (ALFF) has been used as an efficient and reliable neuroimaging marker in the exploration of resting-state regional brain activity in neuropsychiatric disorders, including schizophrenia. [14] [15] [16] [17] [18] It is a whole-brain, resting-state fMRI analysis algorithm used to examine the total power of the local synchronization of spontaneous blood-oxygenation level-dependent signal fluctuations within a specific lowfrequency range (0.01-0.08 Hz) at the single-voxel level. 19 Decreases or increases in ALFF are thought to respectively reflect spontaneous hypo-or hyper-low-frequency fluctuations of neural activity in a certain voxel. 20 Decreased ALFF may indicate a disease-related functional deprivation, while increased ALFF may reflect a compensatory mechanism to maintain normal cognitive performance. Alterations in J Psychiatry Neurosci ALFF in people with schizophrenia have been observed to correlate with both symptom burden 21 and illness duration, 22 which may be modulated using currently available treatments. [23] [24] [25] However, findings from ALFF studies in schizophrenia have been inconsistent. Many studies have observed areas of decreased and increased ALFF in patients with schizophrenia relative to healthy controls, 14, 21, 26, 27 while several other studies have detected only decreased 15, 18 or increased 23 ALFF. In addition, the affected brain regions identified in these studies were diverse: at times, different studies have reported increased or decreased ALFF in the same brain regions. 14, 17, 27, 28 Moreover, some neuroimaging studies have demonstrated that brain abnormalities in each phase (e.g., people likely to develop schizophrenia [ultrahigh risk], patients with first-episode schizophrenia and patients with chronic schizophrenia) were different in the development of schizophrenia. For patients with first-episode schizophrenia, brain abnormalities are thought to be related to genetic, prenatal and environmental factors; 29 patients with chronic schizophrenia, during the progressive stages of illness, had more distractions involving the effects of anti psychotic medication and factors secondary to the illness (such as substance abuse or lifestyle), and brain abnormalities extended to wider areas of the brain. 22, 30 These results may reflect different neural pathophysiologies in the various stages of schizophrenia, so it is important to identify their separate neurobiological markers. Meta-analysis is an effective way of integrating the results of many studies in an unbiased way.
To our knowledge, no one has conducted an ALFF metaanalysis according to the different stages of schizophrenia. Only Xu and colleagues 20 have performed a meta-analysis comparing ALFF differences between 86 patients with schizophrenia and 89 healthy controls using an activation likelihood estimation method. However, they combined the findings of 6 ALFF/fALFF studies and failed to separate patients with first-episode schizophrenia from those with chronic schizophrenia, probably because very few primary studies had been published at the time. Furthermore, they did not consider other confounding clinical variables such as drug treatments, illness duration, and Positive and Negative Syndrome Scale (PANSS) scores in their analysis. In this context, we considered it timely to conduct a meta-analysis to identify the most consistent and replicable ALFF changes in schizophrenia -particularly at different stages (i.e., first-episode and chronic). In the present study, we used seed-based d mapping (SDM), a well-established and validated meta-analytic tool for neuroimaging studies that has been widely used to detect the most spatially consistent structural and functional brain changes in a number of neuropsychiatric diseases. [31] [32] [33] We also conducted meta-regression analyses to explore the potential associations between clinical variables (illness duration and PANSS scores) and ALFF changes. We hypothesized that all patients with schizophrenia, as well as patients with first-episode or chronic schizophrenia, would show distinct ALFF abnormalities in the large-scale brain networks.
Methods

Data sources, study selection and quality assessment
We conducted a comprehensive search of studies published between Jan. 1, 2000, and Apr. 24, 2018, using the PubMed, Embase, Web of Science, SinoMed, Chinese National Knowledge Infrastructure and WanFang databases and the Medical Subject Heading (MeSH) keywords "schizophrenia" OR "schizoaffective disorder" OR "schizophrenic disorder" OR "disorder, schizophrenic" OR "schizophrenic disorders" OR "dementia praecox"; AND "amplitude of low-frequency fluctuation" OR "ALFF" OR "low-frequency fluctuation" OR "LFF" OR "amplitude of low-frequency oscillation" OR "LFO." We also checked the reference lists of the included studies and relevant review articles to identify additional relevant studies.
Studies that satisfied the following conditions were included in the meta-analysis: patients had been diagnosed with schizophrenia between the ages of 18 and 60 years; ALFF comparison of patients with schizophrenia versus healthy controls was conducted; 3-dimensional coordinates (Talairach or Montreal Neurological Institute) were reported for the whole-brain ALFF analysis; significant results were reported using thresholds for significance that were corrected for multiple comparisons or uncorrected with spatial extent thresholds; and the study was published as an original article (not as a letter or an abstract) in a peer-reviewed English-or Chinese-language journal. Data sets were excluded if patients with schizophrenia were diagnosed with comorbid neurologic or psychiatric diseases (e.g., cognitive impairment or depression); the data were unavailable (e.g., missing neuroanatomical coordinates) even after contacting the authors by email or telephone; the data overlapped with those of another included publication; dynamic and fractional ALFF comparison of patients with schizophrenia versus healthy controls was conducted; a region-of-interest approach was used; ALFF comparison between patients with early-onset schizophrenia and healthy controls or first-degree relatives of patients with schizophrenia and healthy controls was conducted; or the ALFF study did not cover the complete band-pass data.
We used a 10-point checklist employed in previous metaanalyses of resting-state fMRI studies to assess the quality of each study selected for meta-analysis (Appendix 1, Table S1 , available at jpn.ca/180245-a1). 34, 35 The literature search, study evaluation and study selection were conducted independ ently by 2 investigators (J.Y.G. and X.M.L.). Any discrepancies were resolved by a third investigator (Y.W.) for a final decision. The current study was conducted with reference to the Metaanalysis of Observational Studies in Epidemiology (MOOSE) guidelines for the meta-analyses of observational studies. 36 
Data analysis
Voxel-wise meta-analysis We conducted a meta-analysis of ALFF differences between patients with schizophrenia and healthy controls using SDM software (version 5.141 for Windows) in a standard process (www.sdmproject.com).
The SDM approach uses effect sizes to combine reported peak coordinates that are extracted from databases with statistical parametric maps, and it recreates original maps of the effect size of ALFF difference between patients and healthy controls. We performed the analysis as described in the SDM tutorial and related publications 37, 38 and used MRIcron software (www.mricro.com/mricron/) to visualize SDM maps.
We describe the SDM approach briefly here. We first extracted peak coordinates and effect sizes (e.g., t values) for differences in ALFF between patients with schizophrenia and healthy controls from each data set. Then, we recreated a standard Montreal Neurological Institute map of the ALFF differences separately for each data set using an anisotropic Gaussian kernel. The mean map was finally generated by voxel-wise calculation of the random effects mean of the data set maps, weighted by the sample size, intra-data-set variability and between-data-set heterogeneity. To optimally balance false positives and negatives, we used the default SDM kernel size and thresholds (full width at half maximum [FWHM] = 20 mm; p = 0.005, uncorrected for false discovery rate; peak height Z = 1; cluster extent = 10 voxels). 37, 38 This FWHM kernel was intended to assign indicators of proximity to reported coordinates but not to smooth any image that was different in nature.
We first conducted the meta-analysis in all patients with schizophrenia; then, we did the same for the subgroup analysis of patients with first-episode (those with an illness duration of less than 2 years) and chronic (those with an illness duration of more than 2 years) 22, 39 schizophrenia. We also conducted the same analysis in medication-naïve patients with first-episode schizophrenia. We also applied the following analyses to the above 3 types of meta-analysis.
Jackknife sensitivity analysis
After preprocessing of the data, we performed a whole-brain voxel-based jackknife sensitivity analysis to test the robustness of the findings by iteratively repeating the same analysis, excluding one data set at a time. 38, 40 We did this to establish the extent to which the results could be replicated. If a brain region remained significant in all or most of the combinations of studies, we considered the finding to be highly replicable.
Analysis of heterogeneity and publication bias
We conducted a heterogeneity analysis using a randomeffects model with Q statistics to explore unexplained between-study variability in the results. We obtained heterogeneous brain regions using the default SDM kernel size and thresholds (FWHM = 20 mm; p = 0.005, uncorrected for false discovery rate; peak height Z = 1; cluster extent = 10 voxels). 37, 38 We also performed Egger's test using Stata/SE 12.0 software for Windows (Stata Corp LP) to assess possible publication bias by extracting the values from statistically significant relevant peaks between patients with schizophrenia and healthy controls. 41 A p value of less than 0.05 was considered significant.
Meta-regression analyses
We carried out meta-regression analyses to explore the associations between the results of the analysis and clinical variables (e.g., illness duration, PANSS scores). The results were weighted by the square root of the sample size. To minimize the reporting of spurious relationships, we select ed a more conservative threshold of p = 0.0005 as used in previous studies, 38, 42 requiring abnormalities to be detected both in the slope and in one of the extremes of the regressor, and discarding findings in regions other than those detected in the main analyses.
Results
Included studies and sample characteristics
After initially removing duplicates and reviewing the titles and abstracts of the 411 relevant documents found through the search strategy, we identified 51 studies as potentially eligible for inclusion. After a detailed review of full article texts, we excluded 27 studies: 10 studies investigated fALFF differences between patients with schizophrenia and healthy controls; [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] 2 studies reported the dynamic ALFF differences; 53,54 2 did not cover the complete band-pass data; 55,56 5 did not use whole-brain analysis; 57-61 2 did not report whole-brain stereotactic coordinates; 28,62 4 focused on first-degree relatives; [63] [64] [65] [66] and 2 investigated ALFF differences between patients with early-onset schizophrenia and healthy controls. 67, 68 In the end, 24 studies reporting 28 data sets that investigated ALFF differences between patients with schizophrenia and healthy controls were eligible for inclusion. [14] [15] [16] [17] [18] 21, 23, [25] [26] [27] [28] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] Of these, 11 (13 data sets) were first-episode samples 14, 15, 18, 21, 23, 25, 26, 69, 71, 76, 81 and 13 (15 data sets) were chronic samples. 16, 17, 27, 28, 70, [72] [73] [74] [75] [77] [78] [79] [80] Of the first-episode samples, 69% were medication-naïve; the results for medication-naïve patients with first-episode schizophrenia are shown in Appendix 1, Figure S1 and Table  S2 .) A flow diagram depicting the identification and exclusion of studies is presented in Figure 1 .
The included data sets reported ALFF differences between 1249 patients with schizophrenia (583 with first-episode schizophrenia and 666 with chronic schizophrenia; 721 males and 528 females; mean age 28.93 yr; mean illness duration 70.23 mo) and 1179 healthy controls (636 males and 543 females; mean age 29.80 yr). We observed no significant differences between patients with schizophrenia and healthy controls with respect to age (standardized mean difference ~0; 95% confidence interval −4.066 to 3.082; t = −0.276; p = 0.78) or sex distribution (χ 2 = 0.961; p = 0.33). Three of 24 included studies were performed on a 1.5 T scanner, and 21 were performed on a 3 T scanner. The demographic, clinical and imaging characteristics of the included studies, as well as quality scores, are summarized in Table 1 .
Voxel-wise meta-analysis
As illustrated in Figure 2 , the meta-analysis brain map showed both decreased and increased ALFF in patients with schizophrenia relative to healthy controls. The total J Psychiatry Neurosci sample of patients with schizophrenia displayed decreased ALFF in the bilateral postcentral gyrus, bilateral precuneus, left inferior parietal gyri (IPG) and right occipital gyrus, and increased ALFF in the right putamen, right inferior frontal gyrus (IFG), left inferior temporal gyrus (ITG) and right anterior cingulate cortex (ACC).
In the subgroup analyses, we observed decreased ALFF in patients with first-episode schizophrenia mainly in the bilateral IPG, right precuneus and left medial prefrontal cortex (mPFC) and increased ALFF in the bilateral putamen and bilateral occipital gyrus. The results for medication-naïve patients with first-episode schizophrenia remained similar for the putamen, mPFC, angular gyrus/IPG and precuneus, but not for the occipital gyrus (Appendix 1, Figure S1 and Table  S2 ). In patients with chronic schizophrenia, we detected decreased ALFF largely in the bilateral postcentral gyrus, left precuneus and right occipital gyrus, and increased ALFF in the bilateral IFG, bilateral superior frontal gyrus (SFG), left amygdala, left ITG, right ACC and left insula. The results for the SDM analysis are summarized in Table 2 .
Jackknife sensitivity analysis
A jackknife sensitivity analysis revealed that in all patients with schizophrenia, the most robust findings were for increased ALFF in the right putamen, right IFG and left ITG, and decreased ALFF in the right postcentral gyrus and left precuneus, replicable in all 28 data sets. Increased ALFF in the right ACC and right IFG and decreased ALFF in the right precuneus and right occipital gyrus also remained replicable, because they were significant in at least 26 of the 28 data sets. Lei et al. 81 (2015) 124 (61) 102 (50) 24.5 ± 6.7
24.8 ± 6.9
6.9 ± 8.5
88. 
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In patients with first-episode schizophrenia, the most robust data were for increased ALFF in the bilateral putamen and decreased ALFF in the left SFG, right IPG and right precuneus, replicable in all 13 data sets. Increased ALFF in the bilateral occipital gyrus and decreased ALFF in the left IPG were replicated in at least 11 of the 13 data sets.
In patients with chronic schizophrenia, the most robust data were for increased ALFF in the left amygdala, right IFG and left ITG, and decreased ALFF in the bilateral postcentral gyrus, left precuneus and right occipital gyrus, replicable in all 15 data sets. Increased ALFF in the right ACC, left IFG, left insula and bilateral SFG, and decreased ALFF in the right occipital gyrus were replicated in at least 11 of the 15 data sets ( Table 2 ).
Analysis of heterogeneity and publication bias
The analysis of heterogeneity revealed that some regions with altered ALFF showed significant unexplained between-study variability in all patients with schizophrenia Table S3 ).
The analysis of publication bias revealed that the Egger test was significant for the left ITG, right SOG and right calcarine gyrus in all patients with schizophrenia; for the right IPG and right precuneus in patients with firstepisode schizophrenia; and for the left IFG, left insula, right SFG and right calcarine gyrus in patients with chronic schizophrenia.
Meta-regression analyses
In all patients with schizophrenia, meta-regression analysis indicated that a higher PANSS total score was correlated with greater increases in ALFF in the right putamen and SOG, and lesser decreases in the left ITG, right IFG and ACC. In patients with first-episode schizophrenia, PANSS total score was not associated with schizophrenia-related ALFF changes. In patients with chronic schizophrenia, higher PANSS total score exhibited lesser decreases in ALFF in the right IFG, ACC and left ITG. Mean illness duration was not associated with any schizophrenia-related ALFF changes. The results of the meta-regression analyses are presented in Table 3 and Appendix 1, Table S4 (subscale scores).
Discussion
As far as we know, the current study is the first quantitative meta-analysis to combine whole-brain ALFF findings from resting-state fMRI studies in patients at different stages of schizophrenia in a voxel-wise manner. The results of our metaanalysis displayed decreased ALFF in the default mode network (DMN), sensorimotor network (SMN) and visual network (VN) regions, and increased ALFF in the putamen, salience network (SN) and frontotemporal regions in all patients with schizophrenia. In the subgroup analysis, patients with first-episode schizophrenia showed decreased ALFF in the DMN regions and increased ALFF in the putamen and VN regions; moreover, the results for the DMN and putamen regions remained consistent in medication-naïve patients with first-episode schizophrenia. In patients with chronic J Psychiatry Neurosci schizophrenia, decreased ALFF was largely detected in the DMN, SMN and VN regions and increased ALFF mainly in the SN and frontotemporal regions. These results overlapped somewhat with those of a previous study, 20 except for an extremely significant increase of ALFF in the putamen in patients with first-episode schizophrenia and much more widespread brain functional damage in patients with chronic schizophrenia. Although the included studies showed some heterogeneity and publication bias, we verified the main results to be highly replicable and stable using jackknife sensitivity analysis. Meta-regression analyses demonstrated that in all patients with schizophrenia and patients with chronic schizophrenia, ALFF alterations involving the putamen, SOG, IFG, ACC and ITG were correlated with PANSS total score.
ALFF alterations in patients with first-episode schizophrenia
Our meta-analysis found consistent regions of decreased ALFF in the DMN in patients with schizophrenia, particularly in the first-episode stage, including the bilateral IPG, right precuneus and left mPFC, suggesting disruption in the DMN regions in the early course of the disorder. Furthermore, medication-naïve first-episode patients displayed decreased ALFF in the DMN, including the right angular gyrus/ IPG, right precuneus and left mPFC. This finding was inconsistent with the results of a recent meta-analysis on ALFF abnormalities in first-episode and drug-naïve patients with schizophrenia, which reported decreased ALFF in the right cerebellar lobule VIII, left cerebellar lobule IX and right cerebellar Crus I. 82 This inconsistency may be attributed to inadequate sample size (smaller than ours, 783 patients and 704 healthy controls) and participant demographic characteristics (including patients with early-onset schizophrenia, 13 to 18 years old), which may have weakened the efficacy of the meta-analysis. Our findings in the DMN were in similar regions to those of reduced grey matter volume in schizophrenia reported in a meta-analysis of voxel-based morphometry studies. 83 The DMN (including the PCC/precuneus, mPFC and IPG) plays an important role in cognitive performance, such as autobiographical memory, decision-making, mental theory and monitoring of the surrounding environment. 84 The DMN has recently attracted attention as a novel means of understanding the neural mechanisms of schizophrenia. Aberrant intrinsic connectivity and activity patterns of the DMN in schizophrenia have been documented in many reports and also associated with social cognition and social functioning impairments, 13, 85, 86 executive deficits, 87 self-referential processing abnormalities, 88 dysfunction of autobiographical memory, 89 auditory-verbal hallucinations 90, 91 and abnormal attentional control processing. 92 As the core of the DMN, the mPFC is important for the affective value of re inforcers, decision-making, the generation and regulation of negative emotion, social cognition and expectation. 93 The IPG, one of the major connection hubs, is associated with constructing mental scenes, episodic memory, spatial attention and language processing. 94, 95 The precuneus has been implicated in the neural processing of retrieval of autobiographical epi-sodic memory, as well as self-referential tasks. 96 In this metaanalysis, decreased ALFF in the precuneus was also found in patients with schizophrenia at different stages (first-episode and chronic). Our results forcefully identify for the first time the most reliable brain areas of ALFF alteration in the DMN that play critical roles in the pathophysiology of schizophrenia. These findings were not affected by illness duration, suggesting that such changes were independent of the disease stages that occur early in schizophrenia, and they might serve as potential neuroimaging biomarkers. The current meta-analysis found increased ALFF in the putamen in patients with schizophrenia, particularly in those with first-episode schizophrenia (including medication-naïve patients). The putamen is a portion of the striatum, which includes 3 main functional subregions-sensory movement, cognition and limbic (or emotion/motivation)-playing a critical role in multiple aspects of motor function, executive/ associative function and emotion/motivation. 97 Structural and functional abnormalities of the putamen have been found in schizophrenia using MRI. The involvement of the putamen in speech production and language processing has been reported, 98, 99 and lower volume and hyperconnectivity in the putamen have been found in patients with schizophrenia with auditory-verbal hallucinations. 100, 101 Another study revealed that decreased ALFF in the left putamen was relatively specific to auditory-verbal hallucinations, 26 and putamen volume loss may be a biological correlate of delusions in schizophrenia. 102 The putamen also has widespread 
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connections with the frontal cortex, involved in motor sequence performance and habitual instrumental behaviour; executive function and goal-directed behaviour; emotion processing; and reinforcement learning. 103 In our metaanalysis, the increased cluster of putamen in patients with first-episode schizophrenia did not appear in patients with chronic schizophrenia; we speculate that increased ALFF in the putamen plays an important compensatory mechanism for maintaining normal cognitive performance in the early stages of schizophrenia. Interestingly, our study observed an inconsistent activation in the VN regions (occipital gyrus, including BA 17, 18 and 19) . We found increased ALFF in the patients with firstepisode schizophrenia and decreased ALFF in patients with chronic schizophrenia, suggesting altered intrinsic activity in the VN. In schizophrenia, both structural and functional abnormalities in the VN have been previously reported. For example, the association of visual hallucinations with VN damage in schizophrenia has already been demonstrated, as well as a decrease in the overall volume of the occipital gyrus, and reduction in magnetization transfer ratio and fractional anisotropy in the white matter adjacent to visual processing regions in patients with schizophrenia. 22, 104, 105 A recent fMRI study proved that patients with schizophrenia have decreased activation in the VN during performance of several cognitive tasks. 104 Diminished strength of functional connectivity and reduced ALFF during the resting state in patients with schizophrenia have also been found throughout the VN. 16, 106 Therefore, it is possible that decreased ALFF in the VN in patients with chronic schizophrenia correlate with vision impairment, while increased ALFF in the VN in first-episode patients plays an important role in vision compensation for schizophrenia.
ALFF alterations in patients with chronic schizophrenia
Dividing the longitudinal course of a disease into different stages (ultra-high risk, first-episode and chronic schizophrenia) might reveal different dynamic and pathophysiological processes that occur in the brain at different times. Our metaanalysis approach involving data sets in chronic schizophrenia from different regions showed that ALFF differences compared with healthy controls and patients with firstepisode schizophrenia became much more widespread, most prominently including decreased ALFF in the DNM (precuneus), SMN (postcentral gyrus) and VN (occipital gyrus), and increased ALFF in the SN (amygdala, insula, IFG and ACC) and frontotemporal regions (SFG, IFG and ITG). Decreased ALFF in the SMA and VN, and increased ALFF in the SN and frontotemporal regions, reflects a progressive imbalance between the primary and advanced functional areas, which might be related to abnormal function patterns in patients with chronic schizophrenia. However, it remains difficult to control for the effects of antipsychotic medication and factors secondary to the illness (such as substance abuse or lifestyle) on brain structure. Moreover, meta-regression analyses revealed that the ALFF in the ACC, IFG and ITG were correlated with PANSS total score, suggesting that the damage to SN and ITG activity was more serious with more severe clinical symptoms of schizophrenia.
The SMN is known to play a key role in the processing of colour, form perception, motion, stereopsis, depth, orientation and subserving motor control, action selection, preparation and motor execution, especially for internally generated movement. 107, 108 Schizophrenia commonly exhibits a variety of symptoms, such as psychomotor and fine-motor symptoms, as well as touch, temperature, nociception, tension and vibration abnormalities. Functional 107,109 and structural 110, 111 abnormalities in the SMA have been reported that may be correlated with the increased involuntary movements, severe motor impairments and neurologic soft signs (describing neurologic abnormalities in sensory integration, motor regulation, sequencing of complex motor acts and primitive reflexes) that occur in the majority of patients with schizophrenia. 112 Our finding, which was consistent with those of another meta-analysis 20 and the findings described above, may provide further evidence that the SMN plays a key role in the psychomotor symptoms of schizophrenia. Decreased intrinsic activity in the bilateral postcentral gyrus may serve as a differentiating feature of chronic schizophrenia.
The current meta-analysis found increased ALFF in the SN (including the left amygdala, left insula, bilateral IFG [BA 47] and right ACC) in patients with chronic schizophrenia. The SN plays a central role in emotion processing and autonomic regulation. It has been proposed to function in the identification of internal and external stimuli (salience) and the shifting of brain function from DMN to central executive network activities. 113 Several schizophrenia symptoms (e.g., hallucinations, delusions, disorganization and psychomotor poverty) and deficits in cognitive function may be related to SN dysfunction. [114] [115] [116] Meta-analyses of neuroimaging studies in schizophrenia have reported reductions in the volume of the constituent regions of the SN, 117 its internal coherence and its integration within the brain functional connectome. 118 Decreased connectivity between the SN and the calcarine fissure was found, significantly correlated with PANSS score. 10 Increased functional connectivity strength in the insula 119 and ACC, 120 and increased intra-SN temporal dynamics of the connectivity were also found, 121 similar to our observation of comprehensive increases in the SN in ALFF studies of chronic and total patients with schizophrenia. Thus, the SN is unstable in schizophrenia, and this could play a functional compensation role for the systematic structural anomalies found in schizophrenia.
We also identified increased ALFF in the frontotemporal regions (including the bilateral SFG, IFG and left ITG) in patients with chronic schizophrenia. Our meta-regression analyses also revealed that the increased ALFF in the frontotemporal lobe was negatively correlated with PANSS total score, suggesting that the brain activity damage was more serious with the progression of disease. Task-based fMRI studies found an increase in oxy-hemoglobin in the frontal and temporal regions in patients with schizophrenia during the verbal fluency task. 122 The frontal lobe, which includes the language-related areas in the IFG (Broca's area), is critically involved in speech production and language processing. 123 It is functionally connected with the temporal lobe to form a language network; its dysfunction has been correlated with delusions, blunted affect and thought disorders in schizophrenia. 30 Our ALFF analysis of 666 patients with chronic schizophrenia showed increased ALFF changes in the IFG, but unlike the findings of Li and colleagues, 30 the increased functional connectivity involving the IFG presented only in first-episode patients, suggesting that the IFG is responsible for the core pathogenesis in the entire course of schizophrenia. Further work using other structural, functional and meta bolic methods are needed to examine this hypothesis.
Limitations
Our study had several limitations. First, given a lack of data, the sample size of our subgroup analysis on the first-episode and chronic patients was somewhat small, and some of the results should be interpreted with caution. As well, we selected a duration-based definition for first-episode schizophrenia of less than 2 years, 22, 39 while some studies have selected patients with disease durations of less than 1, 3 or 5 years to define first-episode schizophrenia. 14, 18, 21 Given that a patient in the first-episode group may have a second episode during these 2 years, we looked back at the 11 articles included in the first-episode group, and none of the patients had experienced more than 1 episode during their illness dur ation. Moreover, we were unable to conduct subgroup meta-analyses of the studies of people at ultra-high risk of developing schizophrenia because of a limited number of data sets (only 4 studies). Second, our meta-analysis included mainly Asian samples (23/28 Asian, 3/28 European, 2/28 American), which may limit the application of these findings to other populations. Further efforts are needed to expand the ALFF method to other schizophrenia populations. Third, our meta-analysis is based on coordinates from studies rather than on raw data, limiting its accuracy. 40 Further studies with large homogeneous samples are needed to verify our results. Fourth, the Egger test indicated a potential publication bias in the subgroup analysis; it will be important to validate our findings with an updated meta-analysis. Fifth, the sample included in the chronic schizophrenia group had a relatively wide age range, but the sample included in the first-episode schizophrenia group was mostly in their 20s. Thus, our results should be interpreted cautiously and regard age as a covariate when comparing first-episode with patients with chronic schizophrenia. Finally, we found substantial heterogeneity in our results for some regions with altered ALFF, a finding that may be attributed to the clinical diversity of the participants and the methodological and statistical diversity of the studies, partially limiting the interpretability and generalizability of the results.
Conclusions
Our comprehensive meta-analysis suggests that during the initial stages of schizophrenia (that is, patients first-episode schizophrenia), aberrant regional intrinsic brain activity predominantly involved the DMN, VN and putamen. With the progression of disease, brain activity abnormalities progressed over time. Patients with chronic schizophrenia demonstrated much more widespread brain functional damage, including the DMN, SN, SMN, VN and frontotemporal regions, contributing to our understanding of the progressive pathophysiology of schizophrenia. Further work is required to determine whether this pattern of altered ALFF can serve as a neuroimaging marker for schizophrenia. 
